10-5-09 Audio Interview with Cellceutix Corp. (OTCBB: CTIX)
October 5th, 2009 | Author: Tom
Podcast: Download (Duration: 12:19 — 11.3MB)
George Evans, the CEO of Cellceutix Corporation (OTCBB:CTIX) an emerging bio-pharmaceutical company in the business of developing small-molecule therapies in areas of unmet medical needs, stopped by SmallCapVoice.com to discuss his exciting young company. Currently the Company owns the rights to seven drug compounds, including Kevetrin, which it is developing as a treatment for certain cancers, and KM-133, which it is developing for psoriasis. For more information, visit: www.cellceutix.com.
Posted in 
Tags: 
